UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances
NeOnc Technologies appointed Ali Alabedin, Head of Islamic Banking Group at First Abu Dhabi Bank, to its board of directors as it pushes a UAE-focused clinical development strategy. Alabedin brings three decades of international banking experience, which the company says could help it navigate multinational clinical, financing and partnership complexities. CEO Amir Heshmatpour is scheduled to speak at the Abu Dhabi Future Health Summit October 20-22.
Key figures
- Fab total assets
- AED 1.41 trillion
- Phase2a patients
- 24
- Pfs 6mo neo100 phase2a
- 48.9%
- Median os neo100 phase2a
- 26.09 months
- Neo212 fda type b meeting
- November 17
- Registered direct offering
- $15 million
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.